Bizarre Patents
Neuroimaging as a Marketing Tool
Neuroimaging as a means for validating whether a stimulus such as advertisement, communication, or product evokes a certain mental response such as emotion, preference, or memory, or to predict the consequences of the stimulus on later behavior such as consumption or purchasing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7981894 | Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride The invention relates to new crystalline modifications of the hydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)-piperazine, crystaline modification of the dihydrochloride of 1-[4-(5-cyanoindol-3-yl) butyl]-4-(2-carbomyl-benzofuran-5-yl)... | 07/19/2011 |
| 7629257 | Combined etching and doping substances The invention concerns etching and doping substances free of hydrochloric/fluoride acid used for etching inorganic layers as well as for doping subjacent layers. The invention also concerns a method wherein said substances are used. ... | 12/08/2009 |
| 7618988 | Use of substituted aminomethyl chromans Compounds of formula I in which R has a meaning as indicated in claim 1, or one of their optical isomers or pharmaceutically acceptable salts, used for the treatment of extrapyramidal movement disorders and/or adverse effects in extrapyramidal movement disord... | 11/17/2009 |
| 7329749 | Piperazinylcarbonylquinolines and -isoquinolines Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkins... | 02/12/2008 |
| 7285681 | Biguanide derivatives The present invention relates to biguanide derivatives of formula (I), wherein R1, R2, R3 and R4 have the meanings as given in claim (1). Compounds are useful in the treatment of pathologies associated with hyperglycaemia, such as diabetes. | 10/23/2007 |
| 7271302 | Method for brominating organic compounds The present invention relates to processes for the bromination of organic compounds, and to bromination microreactors for carrying out these processes. ... | 09/18/2007 |
| 7264795 | Sunscreen composition The present invention relates to a composition having UV protection properties, charaterized in that the formulation comprises at least one encapsulated organic sunscreen and does not penetrate the skin essentially. ... | 09/04/2007 |
| 7264670 | Coloured microstructured effect pigments Disclosed are colored flake-form effect pigments comprising one or more layers, where at least one of the layers comprises one or more colorants or is itself a colorant and at least one of the layers has a groove or grid structure, and to processes for the preparati... | 09/04/2007 |
| 7262216 | Benzofuran compounds and their use as antidepressants and anxiolytics Novel benzofuran derivatives of the formula (I) in which R1, R2, X, Y, Z and m have the meanings indicated in Patent Claim 1, they have a strong affinity to the 5-HT1A receptors. The compounds inhibit serotonin reuptake, exhib... | 08/28/2007 |
| 7241502 | Moulded bodies consisting of core-shell particles The invention relates to mouldings having an optical effect which essentially consist of core/shell particles whose shell forms a matrix and whose core is essentially solid and has an essentially monodisperse size distribution, where a difference exists between the ... | 07/10/2007 |
| 7238757 | Oxygen-containing organoaluminium complexes as cocatalysts Disclosed are compounds of formula (I) which compounds are useful as cocatalysts in olefinic polymerisation reactions, e.g., as Ziegler-Natta catalysts. ... | 07/03/2007 |
| 7220464 | Nematic liquid-crystal mixture, and displays containing same A nematic liquid-crystal mixture contains a compound of formula I in which R11 and R12 are as defined in the specification, and a liquid-crystal displays containing same. ... | 05/22/2007 |
| 7208626 | Method for the production of perfluoroalkyl phosphines and the use thereof as perfluoroalkylating reactants The invention relates to a method for producing perfluoroalkyl phosphines, comprising at least one step in which at least one fluoro(perfluoroalkyl)phosphorane is reacted with at least one hydride ion donator, and the use of tris(perfluoroalkyl)phos-phines as perflu... | 04/24/2007 |
| 7199133 | Derivatives of phenoxy-n-′4-(isothiazolindin-1, 1-dioxid-2yl)phenyll-valerian-acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors Novel compounds of formula (I), wherein D, W, X, Y, T and R1 have the meanings cited in claim 1, are inhibitors of coagulation factor Xa and can be used for the prophylaxis and/or therapy of thromboembolic diseases and in the treatment of tumors | 04/03/2007 |
| 7198828 | Liquid-crystalline medium The invention relates to a liquid-crystalline medium which is characterized in that it comprises one or more compounds of the formula A and at least one compound of the formula B | 04/03/2007 |
| 7186358 | Polymer dopants A polymer dopant for electrially conducting, photoconducting and semiconducting components and devices and novel polymers comprising electron accepting groups that are suitable as polymer dopants. ... | 03/06/2007 |
| 7183418 | Mono-, oligo- and polythieno[2,3-b]thiophenes The invention relates to novel mono-, oligo and poly[2,3-b]-thienothiophenes, their use as semiconductors or charge transport materials, in optical, electro-optical or electronic devices like for example liquid crystal displays, optical films, organic field effect t... | 02/27/2007 |
| 7105708 | Method for producing compounds having a CFO bridge The invention relates to a process for the preparation of compounds containing at least one —CF2—O— bridge in the molecule, in which a) an acid is added onto at least one ketene dithioketal, b) the resultant bis(alkylthio)c... | 09/12/2006 |
| 7101537 | Tricyclic quinoxaline and quinoline derivatives as a UV filter The invention relates to the use of quinoxaline derivatives of formula I, represented by formulas 1a and 1b, as photostable UV filters, in particular in cosmetic and pharmaceutical preparations for protecting the human epidermis or human hair against U... | 09/05/2006 |
| 6995241 | Splice variant of head trauma induced cytoplasmatic calcium binding protein ANIC-BP-1B polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ANIC-BP-1B polypeptides and polynucleotides in diagnostic assays. ... | 02/07/2006 |
| 6805923 | Liquid-crystalline medium A liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I in which ... | 10/19/2004 |
| 6800338 | Electro-optical liquid-crystal display To provide an electro-optical liquid-crystal displays with low addressing voltages and low to moderate multiplex ratios, in particular STN displays, organic alignment layers of low layer thickness are utilized. ... | 10/05/2004 |
| 6764722 | Liquid-crystalline medium The invention relates to a liquid-crystalline medium based on a mixture of polar compounds of negative dielectric anisotropy which comprises at least one compound of the formula I1 and at least one compound of the formul... | 07/20/2004 |
| 6592951 | Liquid-crystalline medium A liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I ##STR1## in which R, A, L1, L2 and Y are as de... | 07/15/2003 |
| 6573005 | Doped positive-electrode material in electrochemical cells An electrode having a positive-electrode material. The positive electrode material is a tin oxide doped with F, Cl, Br, I, S, Se, Te, B, N or P anions.... | 06/03/2003 |
| 6564974 | Dispenser for liquids A dispensing appliance for liquids consists of at least one cabinet-like supply module (1) and of a cabinet-like dispensing module (2) connected to the latter. A pull-out trolley (3) can be moved out of the front side of the supply module (1) and serves f... | 05/20/2003 |
| 6559144 | Bicyclic amino acids Compounds of the formula I ##STR1## in which X, Y, Z, R1, R2, R3, R4, R5, R7, R8, R11, m and n have the meanings stated in claim 1, and their physiologically acceptabl... | 05/06/2003 |
| 6551666 | Cyclohexane derivatives and liquid-crystalline medium The invention relates to cyclohexane derivatives of the formula I ##STR1## in which n, m, p, R1, X1, X2, Z1, Z2, Z3, A1 A2 and Y are as defined above.... | 04/22/2003 |
| 6534478 | Cyclic azapeptides with angiogenic effect Compounds of the formula I cyclo-(aArg-aGly-aAsp-aX-aY) I in which aArg, aGly, aAsp, aX and aY have the meanings indicated in claim 1, and their salts, can be used as integrin inhibitors, in particular for the prophylaxis and treatment of diseases of the circ... | 03/18/2003 |
| 6531498 | Isoxazole derivatives to be used as phosphodiesterase VII inhibitors The invention relates to compounds of formula I and to their physiologically acceptable salts and solvates which act as phosphodiesterse VII inhibitors and are thus useful for the treatment of allergic disorders, asthma, chronic bronchitis, atopic dermati... | 03/11/2003 |
| 6531194 | STN liquid-crystal display The invention relates to supertwist liquid-crystal displays (SLCDs) having very short response times and good steepnesses and angular dependences and to the novel nematic liquid-crystal mixtures employed therein, which are distinguished by the fact that t... | 03/11/2003 |
| 6528538 | Cyclic compounds useful in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharamaceutical compositions and preparation process The present invention relates to cyclic compounds which are of the class of compounds of formula I wherein X and Y represent an oxygen atom and to processes for preparing such compounds. The compounds are useful in the treatment of dyslipidemia, atheroscl... | 03/04/2003 |
| 6521303 | Liquid-crystalline medium The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, characterized in that it comprises one or more compounds of the general formula I ##STR1## in which R1, ##STR... | 02/18/2003 |
| 6514524 | Orally administerable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent The present invention relates to an orally administrable galenic formulation allowing improved absorption by the transmembrane or paracellular route in the gastrointestinal tract of active ingredients which are hydrophilic or ionizable in physiological me... | 02/04/2003 |
| 6514527 | Compositions comprising a mixture of bioflavonols The present invention relates to novel compositions containing a mixture of two or three bioflavonols like isoquercetin, quercetin-4'-glycoside, rutin and quercetin, which show differences in their pharmacokinetics. These compositions are useful as food s... | 02/04/2003 |
| 6509340 | Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT1B/1D ligands Amide and urea derivatives of the formula I R1 --(CH2)n --(Y)q --(Z)r --CO--NH--R2 (I) in which R1, n, Y, q, Z, r and R2 have the meanings indicated in Claim 1, are potent 5-HT... | 01/21/2003 |
| 6509499 | Nitromethylthiobenzene derivatives as inhibitors of aldose reductase The invention concerns novel compound of general formula (1) in which: P, T1, T2, X and n are as defined in claim 1, their tautomeric forms, and their additive salts with pharmaceutically acceptable bases. The invention also concerns... | 01/21/2003 |
| 6491930 | Stable cosmetic formulation containing butylmethoxydibenzoylmethane The invention relates e.g. to the use of aldehydes and/or ketones for improving the stability of cosmetic formulations containing butylmethoxydibenzoylmethane as organic light protection filters in conjunction with inorganic light protection filters.... | 12/10/2002 |
| 6479302 | Method for the immunological determination of an analyte The invention concerns a method for the immunological determination of an analyte in a sample using magnetic particles coated with the analyte to be determined or analyte-specific bonding partners and directly detectable non-magnetic particles coated with... | 11/12/2002 |
| 6478967 | Removal of contaminants from biological products The invention relates to methods for separating biological contaminants (viruses, nucleic acids and/or endotoxins) from biological products, or for reducing the content of such biological contaminants in said biological products. The sample (biological pr... | 11/12/2002 |
